misalnya pada IGF-1 (insulin growth factor). Jalur mTOR diaktifkan oleh
sel, termasuk reseptor tirosin kinase dan reseptor sitokin. Dalam hal ini,
3-kinase (PI3K) ini lalu diikuti oleh fosforilasi AKT dan aktivasi mTOR.
REFERENSI
McKinnon, B. D., Kocbek, V., Nirgianakis, K., Bersinger, N. A., & Mueller, M.
D. (2016). Kinase signalling pathways in endometriosis: potential targets
for non-hormonal therapeutics. Human reproduction update, 22(3), 382-
403.
Liu, Y., Qin, X., Lu, X., & Jiang, J. (2019). Effects of inhibiting the
PI3K/Akt/mTOR signaling pathway on the pain of sciatic endometriosis
in a rat model. Canadian journal of physiology and pharmacology,
97(10), 963-970.
Madanes, D., Bilotas, M. A., Bastón, J. I., Singla, J. J., Meresman, G. F.,
Barañao, R. I., & Ricci, A. G. (2020). PI3K/AKT pathway is altered in the
endometriosis patient’s endometrium and presents differences
according to severity stage. Gynecological Endocrinology, 36(5), 436-
440.
Hung, S. W., Zhang, R., Tan, Z., Chung, J. P. W., Zhang, T., & Wang, C. C.
(2021). Pharmaceuticals targeting signaling pathways of endometriosis
as potential new medical treatment: A review. Medicinal Research
Reviews, 41(4), 2489-2564.